Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Biotechnol Lett. 2023 Aug;45(8):1001-1011. doi: 10.1007/s10529-023-03402-x. Epub 2023 Jun 2.
Current research focuses on the soluble and high-level expression of biologically active recombinant human IL-29 protein in Escherichia coli. The codon-optimized IL-29 gene was cloned into the Champion™ pET SUMO expression system downstream of the SUMO tag under the influence of the T7 lac promoter. The expression of SUMO-fused IL-29 protein was compared in E. coli Rosetta 2(DE3), Rosetta 2(DE3) pLysS, and Rosetta-gami 2(DE3). The release of the SUMO fusion partner resulted in approximately 98 mg of native rhIL-29 protein with a purity of 99% from 1 l of fermentation culture. Purified rhIL-29 was found to be biologically active, as evaluated by its anti-proliferation assay. It was found that Champion™ pET SUMO expression system can be used to obtained high yield of biologically active soluble recombinant human protein compared to other expression vector.
目前的研究重点是在大肠杆菌中可溶性和高水平表达具有生物活性的重组人 IL-29 蛋白。经过密码子优化的 IL-29 基因被克隆到 Champion™ pET SUMO 表达系统中,在 T7 lac 启动子的影响下,SUMO 标签位于下游。比较了在大肠杆菌 Rosetta 2(DE3)、Rosetta 2(DE3)pLysS 和 Rosetta-gami 2(DE3)中表达 SUMO 融合的 IL-29 蛋白。SUMO 融合伴侣的释放导致从 1L 发酵培养液中获得约 98mg 的天然 rhIL-29 蛋白,纯度为 99%。通过抗增殖测定评估,发现纯化的 rhIL-29 具有生物活性。与其他表达载体相比,发现 Champion™ pET SUMO 表达系统可用于获得高产量的具有生物活性的可溶性重组人蛋白。